Marrow has long been recognized as a source of osteoprogenitor cells. Such cells are a member of a heterogeneous group of cells that I have termed mesenchymal stem cells (MSCs) because they can be induced to form a number of differentiated mesenchymal cell types. With the realization that many of these MSCs are perivascular cells, pericytes, also comes the realization that they secrete a large array of bioactive molecules that are immunomodulatory and trophic. In this context, the differentiation capabilities are less important than their medicinal capacity and their regenerative potential in a number of diseases and medical conditions. Thus, we propose the suggestion that they could be called medicinal signaling cells (MSCs).
CITATION STYLE
Caplan, A. I. (2013). MSCs as therapeutics. In Mesenchymal Stromal Cells: Biology and Clinical Applications (pp. 79–90). Springer New York. https://doi.org/10.1007/978-1-4614-5711-4_5
Mendeley helps you to discover research relevant for your work.